Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

987
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
987
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

951
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
951
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

1.0K
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
1.0K
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

785
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
785
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

874
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
874
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

1.3K
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Autologous fecal microbiota transplantation restores the infant gut microbiome and metabolome after antibiotics: a case report.

mBio·2026
Same author

Structural insights of <i>mycobacterial</i> ATP synthase and recent updates on molecular recognition of <i>Mtb</i> ATP synthase inhibitors: a review.

Future medicinal chemistry·2026
Same author

Case Report: Fatal prosthetic valve endocarditis due to <i>Staphylococcus lugdunensis</i>-a wolf in coagulase-negative clothing.

Frontiers in medicine·2026
Same author

A Phase III Randomized Trial Comparing Efficacy, Safety, and Immunogenicity of ZRC-3285 vs. Eylea<sup>®</sup> in Patients with Wet Age-Related Macular Degeneration.

Ophthalmology and therapy·2026
Same author

Comparison of the <i>in vitro</i> infectivity of different strains of <i>Theileria parva</i> in the Muguga cocktail vaccine.

Parasitology·2025
Same author

Disease and Antimicrobial Resistance Surveillance for Nile Tilapia Pathogens in Lake Victoria, Kenya.

Journal of fish diseases·2025

Related Experiment Video

Updated: Mar 7, 2026

An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota
07:15

An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota

Published on: July 31, 2019

10.6K

Dietary interventions for modulating the gut microbiome in PCOS management.

Ekta Patel1

  • 1Osteopathic Medical Student (OMSII) Lake Erie College of Osteopathic Medicine, Erie, PA, United States.

Frontiers in Endocrinology
|March 6, 2026
PubMed
Summary

Dietary interventions can improve polycystic ovary syndrome (PCOS) by modulating the gut microbiome, targeting insulin resistance, and reducing inflammation. This approach offers a promising strategy for better metabolic and reproductive health in women with PCOS.

Keywords:
PCOS (polycystic ovarian syndrome)chronic inflammationdiet interventiongut dysbiosisgut microbiome

More Related Videos

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

3.5K
Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome
04:49

Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome

Published on: July 5, 2024

1.9K

Related Experiment Videos

Last Updated: Mar 7, 2026

An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota
07:15

An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota

Published on: July 31, 2019

10.6K
Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

3.5K
Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome
04:49

Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome

Published on: July 5, 2024

1.9K

Area of Science:

  • Endocrinology
  • Nutritional Science
  • Microbiome Research

Background:

  • Polycystic ovary syndrome (PCOS) affects 10% of reproductive-age women, characterized by insulin resistance, androgen excess, and inflammation.
  • Gut microbiome dysbiosis is increasingly implicated in PCOS pathogenesis, contributing to intestinal permeability, endotoxemia, and hormonal/metabolic dysfunction.
  • Diet represents a modifiable factor with potential to restore microbial balance and improve PCOS outcomes.

Purpose of the Study:

  • To synthesize evidence on how diet influences gut microbiome composition in PCOS.
  • To evaluate the impact of specific dietary patterns on microbial diversity, insulin sensitivity, lipid metabolism, and hormonal regulation.
  • To identify dietary components that can ameliorate clinical PCOS outcomes.

Main Methods:

  • A review of observational studies, randomized trials, and meta-analyses was conducted.
  • Examined dietary interventions including the Mediterranean diet, low-glycemic index diets, anti-inflammatory diets, time-restricted eating, and probiotic supplementation.
  • Assessed effects on microbiota, metabolic measures, and hormonal profiles.

Main Results:

  • Dietary interventions beneficially alter gut microbiota, reduce inflammation, improve insulin sensitivity, and lower androgen levels.
  • Specific diets like Mediterranean and low-GI diets, along with time-restricted eating and probiotics (Lactobacillus, Bifidobacterium), show positive effects on PCOS markers.
  • A multi-component dietary plan is proposed, integrating fiber, probiotics, anti-inflammatory nutrients, and structured eating patterns.

Conclusions:

  • Dietary modulation of the gut microbiome is a viable, non-invasive strategy for PCOS management.
  • Nutrition-based interventions targeting key PCOS pathophysiology can improve metabolic and reproductive health.
  • Further long-term randomized trials are necessary to establish causality and personalize dietary recommendations.